Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.
about
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsSarcopenia in heart failure: mechanisms and therapeutic strategiesThe renin-angiotensin system and prevention of age-related functional decline: where are we now?Skeletal muscle apoptotic signaling predicts thigh muscle volume and gait speed in community-dwelling older persons: an exploratory study.Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopeniaCurrent nutritional recommendations and novel dietary strategies to manage sarcopeniaOne size may not fit all: anti-aging therapies and sarcopeniaEffect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.Hypertension and aging.Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats.AT1 receptor blocker losartan protects against mechanical ventilation-induced diaphragmatic dysfunctionLate-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.Fermented Red Ginseng Potentiates Improvement of Metabolic Dysfunction in Metabolic Syndrome Rat Models.Age-dependent changes in mitochondrial morphology and volume are not predictors of lifespan.Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review.Biomarkers for physical frailty and sarcopenia.
P2860
Q27022354-4A6F98BD-F9C2-44F5-88CB-E7D43537B6D3Q28066237-0D52E945-34E9-485D-928D-173CE8C4A18FQ28085528-30FF385D-C91A-43B9-9DF9-C4E176481463Q34184688-7FC2ABA4-1DDA-4C76-A9A7-CC775E08F7B4Q35013600-FF2BAE14-076C-4D22-A641-C792E5FA8036Q35678546-6EFF56C8-CA0B-48FD-8C36-57569955BDF9Q35737337-84B0D154-A363-4211-A9D2-CB4D63119B03Q35740777-2E9EF9CA-85F1-421A-A427-A10DEBDE84F1Q35749354-3E43EFF1-364B-4C62-BDD8-95A648D414D1Q35908858-149C8ED7-9002-4EA7-8915-3444A2E884ACQ36623143-B9B3B7A4-DA8B-4029-8A69-B41B0F83954DQ36670146-23DEBFD5-5422-4A1A-82B4-8764D7214940Q36752364-53E64A50-05B1-4FB8-9FCD-163622228470Q36993333-BDB925F2-1D0B-4AF4-8C60-6990F39DD30DQ37045179-A25AA856-2AF3-415A-BA19-13846D66C459Q37671517-48FD8A94-8ECB-43D0-8EF0-624F12673D16Q37939582-DD6D0D6C-A1E7-444D-98E1-4FABA75DE7EEQ39117124-6FD850C8-1BA6-48B0-B89D-0FD27C6D1E89
P2860
Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Differential effects of enalap ...... scher 344 × Brown Norway rats.
@ast
Differential effects of enalap ...... scher 344 × Brown Norway rats.
@en
type
label
Differential effects of enalap ...... scher 344 × Brown Norway rats.
@ast
Differential effects of enalap ...... scher 344 × Brown Norway rats.
@en
prefLabel
Differential effects of enalap ...... scher 344 × Brown Norway rats.
@ast
Differential effects of enalap ...... scher 344 × Brown Norway rats.
@en
P2093
P2860
P1433
P1476
Differential effects of enalap ...... ischer 344 × Brown Norway rats
@en
P2093
Christy S Carter
Drake Morgan
Gene B Hubbard
Hae Young Chung
Hazel Lees
Jameson DuPree
Michael Daniels
Silvia Giovannini
Thomas C Foster
P2860
P304
P356
10.1007/S11357-010-9196-Y
P577
2010-12-14T00:00:00Z